neil graham e2 white background

Neil Graham

MBBS, MD, MPH - Non-Executive Director

Neil was appointed to the Board of Directors in May 2020. He is an infectious diseases epidemiologist with extensive experience working in biotech and pharmaceutical companies in the development of medicines.

His career has included senior roles overseeing pipeline development and clinical programs. He is currently CMO at Tiziana Life Sciences and a Non‐Executive Director at Aslan Pharmaceuticals Ltd. Previously Dr Graham was VP, Strategic Program Direction, Immunology & Inflammation at Regeneron Inc. From 2007 to 2009 he was Senior Vice President, Program and Portfolio Management at Vertex Inc, from 2005 to 2007 Sr. Vice President, Program and Portfolio Management at Trimeris Inc. and from 2002 to 2005 CMO/Vice-President, Clinical Development at XTL Biopharmaceuticals.

Neil has considerable depth of scientific expertise in immunology and inflammation and is the author of a number of books and publications including a considerable body of work on respiratory illness. He was educated at University of Adelaide (MBBS, MD, MPH).  Between 1993 and 1997 he was Associate Professor of Epidemiology at John Hopkins University School of Hygiene and Public Health with research focused on HIV, tuberculosis and hepatitis.

Neil was educated at University of Adelaide (MBBS, MD, MPH).  Between 1993 and 1997 he was Associate Professor of Epidemiology at John Hopkins University School of Hygiene and Public Health with research focused on HIV, tuberculosis and hepatitis.

Neil is Chair of the Remuneration and Nomination Committee.